About 1,400 shareholders participated in the meeting, which was conducted both on-site and via online livestream. All five agenda items put to a vote were approved as proposed.
In addition to Rim, Executive Vice President Lo Kun, who heads the EPCV Center, was also reappointed as an inside director. Kim Jung-yeon, a professor at Ewha Womans University Law School, was newly appointed as an outside director and audit committee member.
Other approved items included the adoption of financial statements, amendments to the company's articles of incorporation and a cap on executive compensation.
"This year marks our meaningful 15th anniversary," Rim said. "We will continue our efforts to enhance corporate and shareholder value while contributing to the growth of South Korea's bio industry and economy."
Copyright ⓒ Aju Press All rights reserved.